References
[1] Koo B, Kim D, Kweon J, et al. CRISPR/dCas9-mediated biosensor for detection of tick-borne diseases[J]. Sensors and Actuators B: Chemical, 2018, 273: 316-321.
[2] Geraldi A, Giri-Rachman E A. Synthetic biology-based portable in vitro diagnostic platforms[J]. Alexandria journal of medicine, 2018, 54(4): 423-428.
[3] Li Tian, Li Na. Application of CRISPR/Cas-based biosensing platform in molecular diagnosis[J]. Journal of Analysis and Testing, 2022, 41(4): 520-528.
[4] Xu Wenjuan, Song Dan, Chen Dan, et al. Research progress of pathogen detection technology based on CRISPR/Cas biosensor principle[J]. China Biotechnology Journal, 2021, 41(8): 67-74.
[5] GADWAL, A., ROY, D., KHOKHAR, M., et al. CRISPR/Cas-New Molecular Scissors in Diagnostics and Therapeutics of COVID-19[J]. Indian journal of clinical biochemistry: IJCB,2021,36(4):459-467.
[6] Koo B, Kim D, Kweon J, et al. CRISPR/dCas9-mediated biosensor for detection of tick-borne diseases[J]. Sensors and Actuators B: Chemical, 2018, 273: 316-321.
[7] Aquino-Jarquin G. CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic[J]. Nanomedicine: Nanotechnology, Biology and Medicine, 2019, 18: 428-431.
[8] Sun Xiulan, Fu Xuran, Bao Qi, et al. New generation diagnostic technology: CRISPR system and its application in molecular diagnosis[J]. Journal of Food and Biotechnology, 2022, 41(7): 57-70.
[9] Cao Yaling, Ren Feng. Research progress of nucleic acid instant detection based on CRISPR/Cas technology[J]. Chinese Journal of Laboratory Medicine, 2021, 44(9): 864-867.
[10] SINGH, DESH DEEPAK, VERMA, RAVI, TRIPATHI, SUBHASH K., et al. Breast Cancer Transcriptional Regulatory Network Reprogramming by using the CRISPR/ Cas9 System: An Oncogenetics Perspective[J]. 2021,21(31):2800-2813.
[11] Batista AC, Pacheco LG C. Detecting pathogens with Zinc-Finger, TALE and CRISPR-based programmable nucleic acid binding proteins[J]. Journal of microbiological methods, 2018, 152: 98-104.
[12] Liu L, Yang D, Liu G. Signal amplification strategies for paper-based analytical devices[J]. Biosensors and Bioelectronics, 2019, 136: 60-75.
[13] Otlu B. CRISPR-Cas System: A Brief History and Future in the Diagnosis and Treatment of Infectious Diseases[J]. Infectious Diseases and Clinical Microbiology, 2019, 1(1): 2-6.
[14] Jones KA, Zinkus-Boltz J, Dickinson B C. Recent advances in developing and applying biosensors for synthetic biology[J]. Nano Futures, 2019, 3(4): 042002.
[15] Kim CM, Smolke C D. Biomedical applications of RNA-based devices[J]. Current Opinion in Biomedical Engineering, 2017, 4: 106-115.
[16] Choi KR, Jang WD, Yang D, et al. Systems metabolic engineering strategies: integrating systems and synthetic biology with metabolic engineering[J]. Trends in biotechnology, 2019, 37(8): 817-837.
[17] Shi Kai, Lei Chunyang, Nie Zhou. Application progress of CRISPR/Cas technology in nucleic acid detection[J]. Journal of Analysis and Testing, 2018, 37(10): 1217-1220.
[18] GONG, SHAOHUA, ZHANG, SHIQI, LU, FEI, et al. CRISPR/Cas-Based In Vitro Diagnostic Platforms for Cancer Biomarker Detection[J]. Analytical chemistry, 2021, 93(35): 11899-11909.